Apotheek nieuws
- Abenza announces investment in bioconjugation and ADC capabilities
- Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19
- Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA?approved drugs and clinical candidates
- First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus
- Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition
- Umc's slaan handen ineen om pandemische paraatheid te vergroten
- Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
- Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery
- Ministerie van VWS en maatschappelijke organisaties roepen op: Praat vandaag over morgen
- Selvita launches biologic drug discovery and development services
- Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S?600918 and its analogue DDTPA
- Periodic injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts
- MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future [Review article]
- Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology
- Pharmacokinetics of Panobinostat: Interspecies Difference in Metabolic Stability [Metabolism, Transport, and Pharmacogenetics]